HIGHLIGHTS
- who: Samuel Wacrenier from the National Institute of Arthritis and (NIAMS), United States have published the Article: Commentary: Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis, in the Journal: (JOURNAL)
- what: The authors aimed to evaluate the predictive value of these biological markers within the cohort of AAV patients with biopsy-proven kidney involvement, included in the Maine-Anjou (France) registry.
SUMMARY
Diagnosis of Antineutrophil cytoplasmic antibodies (ANCA) associated vasculitis (AAV) with glomerulonephritis (ANCA-GN) enjoins the start of an immunosuppressive treatment as soon as possible. In . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.